73,621 Shares in Kenvue Inc. $KVUE Bought by Commerzbank Aktiengesellschaft FI

Key Points

• Commerzbank Aktiengesellschaft FI acquired 73,621 Kenvue shares in the second quarter, valued at approximately $1.4 million. Institutional investors collectively own 97.64% of Kenvue.
• Kenvue’s shares opened at $18.82, while its latest quarterly results slightly missed analyst expectations: adjusted earnings were $0.31 per share versus $0.32 expected, and revenue was $3.96 billion.
• The company announced a quarterly dividend of $0.21 per share, equivalent to an annualized yield of about 4.5%. Analysts maintain a consensus “Hold” rating with an average price target of $19.27.

Commerzbank Aktiengesellschaft FI bought a new position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 73,621 shares of the company's stock, valued at approximately $1,407,000.

Several other hedge funds also recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Kenvue by 25.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 410,874 shares of the company's stock worth $7,088,000 after purchasing an additional 84,219 shares during the period. Calamos Advisors LLC boosted its stake in shares of Kenvue by 24.1% in the first quarter. Calamos Advisors LLC now owns 3,351,000 shares of the company's stock worth $57,771,000 after acquiring an additional 651,000 shares during the last quarter. State of Wyoming raised its position in shares of Kenvue by 233.5% in the fourth quarter. State of Wyoming now owns 97,992 shares of the company's stock valued at $1,690,000 after buying an additional 68,609 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its stake in Kenvue by 21.5% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 3,491,548 shares of the company's stock worth $60,229,000 after purchasing an additional 618,720 shares in the last quarter. Finally, Cullen Frost Bankers Inc. lifted its position in Kenvue by 19.9% during the fourth quarter. Cullen Frost Bankers Inc. now owns 431,394 shares of the company's stock worth $7,442,000 after buying an additional 71,591 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Trading Up 0.2%

Shares of KVUE stock opened at $18.82 on Wednesday. The company has a market capitalization of $36.15 billion, a P/E ratio of 21.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.47. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $21.84. The business's 50 day moving average is $19.00 and its two-hundred day moving average is $18.16.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). The firm had revenue of $3.96 billion during the quarter, compared to analysts' expectations of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The firm's revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.29 EPS. Equities analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 4.5%. The ex-dividend date is Wednesday, August 12th. This is an increase from Kenvue's previous quarterly dividend of $0.21. Kenvue's payout ratio is presently 96.55%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on KVUE shares. Wall Street Zen lowered shares of Kenvue from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Barclays lifted their target price on Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 21st. Weiss Ratings upgraded Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research note on Monday, June 15th. Zacks Research lowered Kenvue from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 7th. Finally, UBS Group cut their price objective on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Tuesday, August 11th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $19.27.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source